Bridging innovation and clinical reality: Interpreting the comparative study of deep learning models for multi-class upper gastrointestinal disease segmentation

Table 2 Implementation roadmap

Translational challenge	Concrete solution	Responsible stakeholders	Measurable success metrics
Dataset bias and limited diversity	Multi-center data sharing agreements; standardized metadata schema (demographics, device, protocol); stratified sampling and targeted collection for underrepresented cohorts; federated learning to enable cross-site models while preserving privacy	Clinical consortiums, data governance teams, hospital IT, study PIs, legal/compliance	Number of centers and countries represented; device/vendor diversity index; demographic coverage (age/sex/ethnicity) proportions; change in GRR and external IoU on held-out sites
Annotation variability and subjectivity	Develop and enforce standardized annotation protocol and labeling guidelines; multi-expert consensus labeling; adjudication workflows; active learning to prioritize ambiguous cases; periodic re-annotation audits	Clinical experts (gastroenterologists), annotation managers, platform vendors, data scientists	Inter-rater agreement (Cohen’s kappa/mean IoU across annotators); % masks adjudicated; annotation time per case; model performance gains after consensus labels
Class imbalance/rare pathology sensitivity	Oversampling/targeted collection of rare classes; class-aware loss functions (focal, class-weighted); synthetic data and augmentation for rare classes; curriculum learning focusing on rare classes	Data acquisition teams, ML engineers, clinical partners, biostatisticians	Per-class recall/sensitivity (especially for rare classes); AUPRC for rare classes; reduction in false-negative rate for underrepresented labels
Imaging variability (lighting, specular reflection, motion blur)	Advanced preprocessing (illumination normalization, reflection removal), robust augmentation (exposure, blur, specular sim), self-supervised pretraining on large unlabeled endoscopy corpora; spatio-temporal modeling for videos	ML research team, imaging engineers, clinical endoscopy unit, vendors	Performance stratified by exposure/quality buckets (IoU under overexposed vs normal); reduction in failure cases linked to artifacts; frame-level temporal consistency metrics (temporal IoU)
Poor cross-dataset generalization/overfitting	Cross-dataset evaluation, domain adaptation techniques, federated or multi-site training, hold-out external validation sets, regularization and ensembling	ML engineers, external collaborators, validation leads, statisticians	Delta IoU/Dice between internal test and external test sets; GRR improvement on external cohorts; calibration metrics (Brier score)
Real-time performance and resource constraints (PET)	Model compression and pruning; lightweight architectures (e.g., SegFormer variants); hardware benchmark targeting (edge GPU/CPU); optimized inference pipelines	ML engineers, DevOps, clinical IT, hardware vendors	Inference latency (microseconds/frame), throughput (fps) on target hardware; memory usage, FLOPs; PET score or task-specific tradeoff metric; clinician acceptance for live use
Clinical validation and impact on workflow	Prospective clinical studies, reader studies comparing model + clinician vs clinician alone; integration pilots in endoscopy suite; user-centred UI/UX design and training	Clinical investigators, hospital operations, human factors specialists, clinical IT	Diagnostic accuracy improvement (sensitivity/specificity) in prospective trials; change in missed-lesion rate; time-to-report; clinician satisfaction and adoption rates
Trust, explainability and clinician acceptance	Provide visual explanations (attention maps, uncertainty overlays); case-level confidence scores; reporting of failure modes and limitations; clinician training modules	ML explainability team, clinical educators, product managers, regulatory/QA	Proportion of model outputs with uncertainty flags; clinician trust scores in surveys; reduction in dismissed correct alerts; explainability usability ratings
Privacy, legal & regulatory readiness	Data de-identification pipeline, DPIAs, early engagement with regulators, pre-specified validation plan, post-market surveillance plan, robust audit trails	Legal/compliance, regulatory affairs, data governance, QA, cybersecurity	Completion of DPIA and IRB approvals; regulatory submission milestones (pre-submission, submission, approvals); number of privacy incidents; time to resolve security findings
Multi-modal and longitudinal integration	Design multi-modal models (image + report + temporal video), link endoscopy frames with pathology/EMR metadata, adopt interoperable standards (DICOM/HL7/FHIR)	Data engineers, clinical informatics, pathology, ML researchers, standards officers	Increase in model performance when adding modalities (delta IoU/Dice); % cases with linked pathology; successful end-to-end FHIR/DICOM integrations; improvement in clinically-relevant outcome measures (e.g., appropriate biopsy rate)

IoU: Intersection over union; PET: Performance-efficiency trade-off; GRR: Generalization-reliability rate; IT: Information technology; PIs: Principal investigators; ML: Machine learning; QA: Quality assurance; DPIA: Data protection impact assessment; IRB: Institution review board; AUPRC: Area under precision-recall curve.